Success Stories: Without RFE, a PhD Candidate in the Field of Biomedical Engineering Secures I-140 NIW Approval with the Help of Our Expert Team
Client’s Testimonial:
“I would like to thank you for preparing my application! The petition letters you drafted, along with the recommendation letters, are very helpful. My questions have always been answered promptly. Overall, the whole process was fast, smooth, and well-guided. Thank you so much!”
On March 7th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Candidate
Country of Origin: Kazakhstan
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: March 7th, 2025
Processing Time: 12 months
Case Summary:
"In summarizing my support for [Client], it is clear that she is positioned as a biomedical engineering researcher at the highest echelon of our field. She has proven her expertise through her impactful research into antibody monitoring biosensors for the SARS-CoV-2 virus, as well as by her outstanding work in publishing for select venues in the field. Thus, [Client’s] record of achievement to date more than evidences the indispensability of her research to the United States."
The statement above is taken from one of the four recommendation letters submitted as part of the I-140 NIW (National Interest Waiver) petition for a Ph.D. candidate from Kazakhstan who holds an M.S. in biomedical engineering. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition on her behalf.
As an expert in the field of biomedical engineering, her proposed endeavor is to continue her research on engineering innovative biosensors and analytical tools with integrated nanotechnology and photonics to revolutionize molecular identification, sensing, and tissue imaging for environmental monitoring, drug discovery, and disease diagnostics.
We also emphasized that our client’s research is of significant importance and has far-reaching implications for the United States. Her work redefines disease diagnostics, particularly in cancer detection, and addresses a critical need by transforming diagnostic methodologies and improving patient outcomes, particularly in the context of Alzheimer’s disease.
To further strengthen her case, we also highlighted her credentials:
- She has authored 9 peer-reviewed journal articles (6 of them first-authored), 15 peer-reviewed conference articles (4 of them first-authored), 1 first-authored preprint, and 1 conference abstract.
- Her works have been cited a total of 352 times, according to Google Scholar.
- She has been regularly invited to review academic papers and has conducted at least 7 peer reviews to date.